Germany
I am a life science investor working across the full venture investment lifecycle — from identifying promising opportunities and assessing scientific, clinical, and commercial potential to supporting investment decisions and helping advance healthcare innovation toward meaningful patient impact. My work sits at the intersection of venture capital, science, and strategy. I enjoy engaging with entrepreneurs, scientists, management teams, co-investors, and industry partners to understand where differentiated innovation can address important unmet needs and become a compelling investment opportunity. Before moving into venture capital, I worked in healthcare investment banking, where I gained experience across strategic and financing transactions in the healthcare sector. That background continues to shape how I evaluate opportunities: with a focus on clear value-creation milestones, disciplined capital allocation, and long-term strategic relevance. I am particularly interested in therapeutics, medtech, diagnostics, digital health, and business models that can meaningfully improve patient outcomes while building sustainable healthcare companies.